BlackRock Fund Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9.88M Buy
789,210
+90,435
+13% +$1.08M ﹤0.01% 2579
2016
Q3
$9.68M Buy
698,775
+40,856
+6% +$463K ﹤0.01% 2488
2016
Q2
$6.5M Buy
657,919
+51,577
+9% +$855K ﹤0.01% 2656
2016
Q1
$10.3M Buy
606,342
+17,453
+3% +$281K ﹤0.01% 2328
2015
Q4
$13.1M Buy
588,889
+275,432
+88% +$6.95M ﹤0.01% 2293
2015
Q3
$7.39M Sell
313,457
-408
-0.1% -$25.6K ﹤0.01% 2559
2015
Q2
$25.7M Buy
313,865
+127,173
+68% +$12.4M 0.01% 1955
2015
Q1
$17.3M Buy
186,692
+12,041
+7% +$777K ﹤0.01% 2141
2014
Q4
$7.06M Sell
174,651
-131,276
-43% -$4.02M ﹤0.01% 2671
2014
Q3
$7.48M Buy
305,927
+1,300
+0.4% +$20.7K ﹤0.01% 2523
2014
Q2
$4.83M Sell
304,627
-17,716
-5% -$256K ﹤0.01% 2857
2014
Q1
$4.87M Buy
322,343
+23,506
+8% +$365K ﹤0.01% 2833
2013
Q4
$4.11M Buy
298,837
+171,036
+134% +$2.49M ﹤0.01% 2937
2013
Q3
$2.41M Buy
+127,801
New +$2.15M ﹤0.01% 3093

Other funds holding ESPR